Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) Cost of Revenue: 2010-2025

Historic Cost of Revenue for Innoviva (INVA) over the last 4 years, with Sep 2025 value amounting to $25.6 million.

  • Innoviva's Cost of Revenue rose 156.69% to $25.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.1 million, marking a year-over-year increase of 39.00%. This contributed to the annual value of $36.6 million for FY2024, which is 10.82% down from last year.
  • According to the latest figures from Q3 2025, Innoviva's Cost of Revenue is $25.6 million, which was up 142.14% from $10.6 million recorded in Q2 2025.
  • In the past 5 years, Innoviva's Cost of Revenue ranged from a high of $25.6 million in Q3 2025 and a low of $3.7 million during Q3 2022.
  • Over the past 3 years, Innoviva's median Cost of Revenue value was $10.0 million (recorded in 2024), while the average stood at $11.4 million.
  • In the last 5 years, Innoviva's Cost of Revenue skyrocketed by 176.68% in 2023 and then dropped by 19.41% in 2025.
  • Over the past 4 years, Innoviva's Cost of Revenue (Quarterly) stood at $3.7 million in 2022, then spiked by 176.68% to $10.2 million in 2023, then fell by 1.89% to $10.0 million in 2024, then skyrocketed by 156.69% to $25.6 million in 2025.
  • Its last three reported values are $25.6 million in Q3 2025, $10.6 million for Q2 2025, and $8.8 million during Q1 2025.